Patient, caregiver, and oncologist predictions of quality of life in advanced cancer: Accuracy and associations with end-of-life care and caregiver bereavement.

Background: Informed treatment decision-making necessitates accurate prognostication, including predictions about quality of life.

Aims: We examined whether oncologists, patients with advanced cancer, and caregivers accurately predict patients' future quality of life and whether these predictions are prospectively associated with end-of-life care and bereavement.

Materials & Methods: We conducted secondary analyses of clinical trial data.

Prognostic accuracy of patients, caregivers, and oncologists in advanced cancer.

Background: In caring for patients with advanced cancer, accurate estimation of survival is important for clinical decision making. The purpose of this study was to assess the accuracy of 2-year survival probabilities estimated by oncologists, patients, and caregivers and to identify demographic and clinical factors associated with prognostic accuracy.

Methods: This was a secondary observational analysis of data obtained from a cluster randomized controlled trial.

Olanzapine-Induced Neutropenia.

Olanzapine-induced neutropenia is a rare adverse effect that is currently poorly described in literature. Although neutropenia is a known adverse effect of clozapine, it has been associated with the use of other antipsychotic medications like olanzapine. This case report describes and reviews a case of olanzapine-induced neutropenia in a schizophrenic patient.